Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 15.42M | $ 8.22M | 53.32% |
3/31/2025 | $ 6.4M | $ 10.54M | 164.55% |
12/31/2024 | $ 6.17M | $ 8.99M | 145.62% |
9/30/2024 | $ 6.74M | $ 9.08M | 134.63% |
6/30/2024 | $ 10.06M | $ 9.4M | 93.43% |
3/31/2024 | $ 12.99M | $ 9.18M | 70.72% |
12/31/2023 | $ 18.14M | $ 9.3M | 51.27% |
9/30/2023 | $ 22.24M | $ 9.24M | 41.57% |
6/30/2023 | $ 23.54M | $ 8.48M | 36.02% |
3/31/2023 | $ 33.13M | $ 7.58M | 22.87% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for ARBUTUS BIOPHARMA CORP is calculated as follows: SB Comp. [ $ 4.71M ] / Revenues [ $ 6.15M ]
(=) SB Comp % [ 76.59% ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |